<style type="text/css">

   table.tableizer-table {

   border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif

   font-size: 12px;

}

.tableizer-table td {

   padding: 4px;

   margin: 3px;

   border: 1px solid #ccc;

}

.tableizer-table th {

   background-color: #104E8B;

   color: #FFF;

   font-weight: bold;

}

</style>


<hr style='margin-bottom:-5px'>
	<div style="padding-left:40px; padding-right:40px">
		<table class="table-condensed" style="width:100%">
			<td> <h2><strong>Measure List</strong></h2> </td>
			<td colspan='2' align='right'>	
				<%= link_to "Back to Home", "/", class: "btn btn-large btn-success", :style => "float:right"%>
			</td>
		</table>
	</div>
	<hr style="margin-top:-5px">
    
<div id="pageContent" style="margin-left:40px; margin-right:40px; margin-top:10px"> 

	<table class="tableizer-table">

		<tr class="tableizer-firstrow"><th>NQF ID</th><th>CMS ID</th><th>Name</th><th>Subtitle</th><th>Category</th></tr>

		<tr><td>142</td><td>CMS100v2</td><td>Aspirin Prescribed at Discharge</td><td>&nbsp;</td><td>Acute Myocardial Infarction</td></tr>

		<tr><td>639</td><td>CMS30v3</td><td>Statin Prescribed at Discharge</td><td>&nbsp;</td><td>Acute Myocardial Infarction</td></tr>

		<tr><td>163</td><td>CMS53v2</td><td>Primary PCI Received Within 90 Minutes of Hospital Arrival</td><td>&nbsp;</td><td>Acute Myocardial Infarction</td></tr>

		<tr><td>164</td><td>CMS60v2</td><td>Fibrinolytic Therapy Received Within 30 Minutes of Hospital Arrival</td><td>&nbsp;</td><td>Acute Myocardial Infarction</td></tr>

		<tr><td>338</td><td>CMS26v1</td><td>Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver</td><td>&nbsp;</td><td>Asthma</td></tr>

		<tr><td>105</td><td>CMS128v2</td><td>Anti-depressant Medication Management</td><td>180 days</td><td>Behavioral Health Adult</td></tr>

		<tr><td>110</td><td>CMS169v2</td><td>Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use</td><td>&nbsp;</td><td>Behavioral Health Adult</td></tr>

		<tr><td>710</td><td>CMS159v2</td><td>Depression Remission at Twelve Months</td><td>&nbsp;</td><td>Behavioral Health Adult</td></tr>

		<tr><td>712</td><td>CMS160v2</td><td>Depression Utilization of the PHQ-9 Tool</td><td>Jan-Apr</td><td>Behavioral Health Adult</td></tr>

		<tr><td>712</td><td>CMS160v2</td><td>Depression Utilization of the PHQ-9 Tool</td><td>May-Aug</td><td>Behavioral Health Adult</td></tr>

		<tr><td>104</td><td>CMS161v2</td><td>Adult Major Depressive Disorder (MDD): Suicide Risk Assessment</td><td>&nbsp;</td><td>Behavioral Health Adult</td></tr>

		<tr><td>105</td><td>CMS128v2</td><td>Anti-depressant Medication Management</td><td>84 days</td><td>Behavioral Health Adult</td></tr>

		<tr><td>712</td><td>CMS160v2</td><td>Depression Utilization of the PHQ-9 Tool</td><td>Sep-Dec</td><td>Behavioral Health Adult</td></tr>

		<tr><td>4</td><td>CMS137v2</td><td>Initiation and Engagement of Alcohol and Other Drug Dependence Treatment</td><td>Treatment</td><td>Behavioral Health Adult</td></tr>

		<tr><td>4</td><td>CMS137v2</td><td>Initiation and Engagement of Alcohol and Other Drug Dependence Treatment</td><td>Treatment w/ AOD</td><td>Behavioral Health Adult</td></tr>

		<tr><td>4</td><td>CMS137v2</td><td>Initiation and Engagement of Alcohol and Other Drug Dependence Treatment</td><td>Treatment w AOD, RS2: >=18</td><td>Behavioral Health Adult</td></tr>

		<tr><td>4</td><td>CMS137v2</td><td>Initiation and Engagement of Alcohol and Other Drug Dependence Treatment</td><td>Treatment, RS2: >=18</td><td>Behavioral Health Adult</td></tr>

		<tr><td>4</td><td>CMS137v2</td><td>Initiation and Engagement of Alcohol and Other Drug Dependence Treatment</td><td>Treatment w/ AOD, RS1: 13-17</td><td>Behavioral Health Adult</td></tr>

		<tr><td>1401</td><td>CMS82v1</td><td>Maternal Depression Screening</td><td>&nbsp;</td><td>Behavioral Health Adult</td></tr>

		<tr><td>4</td><td>CMS137v2</td><td>Initiation and Engagement of Alcohol and Other Drug Dependence Treatment</td><td>Treatment, RS1: 13-17</td><td>Behavioral Health Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS149v2</td><td>Dementia: Cognitive Assessment</td><td>&nbsp;</td><td>Behavioral Health General</td></tr>

		<tr><td>1365</td><td>CMS177v2</td><td>Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment</td><td>&nbsp;</td><td>Behavioral Health Pediatric</td></tr>

		<tr><td>385</td><td>CMS141v3</td><td>Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients</td><td>&nbsp;</td><td>Cancer</td></tr>

		<tr><td>387</td><td>CMS140v2</td><td>Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer</td><td>&nbsp;</td><td>Cancer</td></tr>

		<tr><td>389</td><td>CMS129v3</td><td>Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients</td><td>&nbsp;</td><td>Cancer</td></tr>

		<tr><td>384</td><td>CMS157v2</td><td>Oncology: Medical and Radiation – Pain Intensity Quantified</td><td>&nbsp;</td><td>Cancer</td></tr>

		<tr><td>147</td><td>CMS188v3</td><td>Initial Antibiotic Selection for Community-Acquired Pneumonia (CAP) in Immunocompetent Patients</td><td>non-ICU patients</td><td>Community Acquired Pneumonia</td></tr>

		<tr><td>147</td><td>CMS188v3</td><td>Initial Antibiotic Selection for Community-Acquired Pneumonia (CAP) in Immunocompetent Patients</td><td>ICU patients</td><td>Community Acquired Pneumonia</td></tr>

		<tr><td>36</td><td>CMS126v2</td><td>Use of Appropriate Medications for Asthma</td><td>RS3: 19-50</td><td>Core</td></tr>

		<tr><td>36</td><td>CMS126v2</td><td>Use of Appropriate Medications for Asthma</td><td>RS2: 12-18</td><td>Core</td></tr>

		<tr><td>418</td><td>CMS2v3</td><td>Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>BMI Recorded, RS2: 12-17</td><td>Core</td></tr>

		<tr><td>421</td><td>CMS69v2</td><td>Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up</td><td>18-64</td><td>Core</td></tr>

		<tr><td>108</td><td>CMS136v3</td><td>ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication</td><td>Visit within 30 days</td><td>Core</td></tr>

		<tr><td>22</td><td>CMS156v2</td><td>Use of High-Risk Medications in the Elderly</td><td>2+ High-Risk Medications</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>Physical Activity Counseling</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>Nutrition Counseling, RS2: 12-17</td><td>Core</td></tr>

		<tr><td>&nbsp;</td><td>CMS75v2</td><td>Children Who Have Dental Decay or Cavities</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>Physical Activity Counseling, RS2: 12-17</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>BMI Recorded, RS1: 3-11</td><td>Core</td></tr>

		<tr><td>18</td><td>CMS165v2</td><td>Controlling High Blood Pressure</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>36</td><td>CMS126v2</td><td>Use of Appropriate Medications for Asthma</td><td>RS4: 51-64</td><td>Core</td></tr>

		<tr><td>33</td><td>CMS153v2</td><td>Chlamydia Screening for Women</td><td>RS2: 21-24</td><td>Core</td></tr>

		<tr><td>36</td><td>CMS126v2</td><td>Use of Appropriate Medications for Asthma</td><td>RS1: 5-11</td><td>Core</td></tr>

		<tr><td>22</td><td>CMS156v2</td><td>Use of High-Risk Medications in the Elderly</td><td>1+ High-Risk Medications</td><td>Core</td></tr>

		<tr><td>419</td><td>CMS68v3</td><td>Documentation of Current Medications in the Medical Record</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>421</td><td>CMS69v2</td><td>Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up</td><td>65+</td><td>Core</td></tr>

		<tr><td>36</td><td>CMS126v2</td><td>Use of Appropriate Medications for Asthma</td><td>May-64</td><td>Core</td></tr>

		<tr><td>108</td><td>CMS136v3</td><td>ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication</td><td>Visit with 2+ followups</td><td>Core</td></tr>

		<tr><td>&nbsp;</td><td>CMS90v3</td><td>Functional Status Assessment for Complex Chronic Conditions</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>&nbsp;</td><td>CMS50v2</td><td>Closing the referral loop: receipt of specialist report</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>BMI Recorded</td><td>Core</td></tr>

		<tr><td>33</td><td>CMS153v2</td><td>Chlamydia Screening for Women</td><td>16-24</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>Physical Activity Counseling, RS1: 3-11</td><td>Core</td></tr>

		<tr><td>2</td><td>CMS146v2</td><td>Appropriate Testing for Children with Pharyngitis</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>33</td><td>CMS153v2</td><td>Chlamydia Screening for Women</td><td>RS1: 16-20</td><td>Core</td></tr>

		<tr><td>28</td><td>CMS138v2</td><td>Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>Nutrition Counseling</td><td>Core</td></tr>

		<tr><td>69</td><td>CMS154v2</td><td>Appropriate Treatment for Children with Upper Respiratory Infection (URI)</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>24</td><td>CMS155v2</td><td>Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents</td><td>Nutrition Counseling, RS1: 3-11</td><td>Core</td></tr>

		<tr><td>38</td><td>CMS117v2</td><td>Childhood Immunization Status</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>52</td><td>CMS166v3</td><td>Use of Imaging Studies for Low Back Pain</td><td>&nbsp;</td><td>Core</td></tr>

		<tr><td>&nbsp;</td><td>CMS74v3</td><td>Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists</td><td>RS3: 13-20</td><td>Dental</td></tr>

		<tr><td>&nbsp;</td><td>CMS74v3</td><td>Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists</td><td>0-20</td><td>Dental</td></tr>

		<tr><td>&nbsp;</td><td>CMS74v3</td><td>Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists</td><td>RS1: <= 5</td><td>Dental</td></tr>

		<tr><td>&nbsp;</td><td>CMS74v3</td><td>Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists</td><td>RS2: 6-12</td><td>Dental</td></tr>

		<tr><td>62</td><td>CMS134v2</td><td>Diabetes: Urine Protein Screening</td><td>&nbsp;</td><td>Diabetes</td></tr>

		<tr><td>88</td><td>CMS167v2</td><td>Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy</td><td>&nbsp;</td><td>Diabetes</td></tr>

		<tr><td>56</td><td>CMS123v2</td><td>Diabetes: Foot Exam</td><td>&nbsp;</td><td>Diabetes</td></tr>

		<tr><td>60</td><td>CMS148v2</td><td>Hemoglobin A1c Test for Pediatric Patients</td><td>&nbsp;</td><td>Diabetes</td></tr>

		<tr><td>59</td><td>CMS122v2</td><td>Diabetes: Hemoglobin A1c Poor Control</td><td>&nbsp;</td><td>Diabetes</td></tr>

		<tr><td>89</td><td>CMS142v2</td><td>Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care</td><td>&nbsp;</td><td>Diabetes</td></tr>

		<tr><td>64</td><td>CMS163v2</td><td>Diabetes: Low Density Lipoprotein (LDL) Management</td><td>&nbsp;</td><td>Diabetes</td></tr>

		<tr><td>497</td><td>CMS111v2</td><td>Median Admit Decision Time to ED Departure Time for Admitted Patients</td><td>RS2: ED and inpatient w/out psych</td><td>Emergency Department</td></tr>

		<tr><td>495</td><td>CMS55v2</td><td>Median Time from ED Arrival to ED Departure for Admitted ED Patients</td><td>RS2: ED and inpatient w/out psych</td><td>Emergency Department</td></tr>

		<tr><td>495</td><td>CMS55v2</td><td>Median Time from ED Arrival to ED Departure for Admitted ED Patients</td><td>RS1: ED and inpatient</td><td>Emergency Department</td></tr>

		<tr><td>496</td><td>CMS32v3</td><td>Median Time from ED Arrival to ED Departure for Discharged ED Patients</td><td>RS1: With ED Encounter</td><td>Emergency Department</td></tr>

		<tr><td>497</td><td>CMS111v2</td><td>Median Admit Decision Time to ED Departure Time for Admitted Patients</td><td>RS1: ED and inpatient</td><td>Emergency Department</td></tr>

		<tr><td>496</td><td>CMS32v3</td><td>Median Time from ED Arrival to ED Departure for Discharged ED Patients</td><td>RS2: With Mental Disorders</td><td>Emergency Department</td></tr>

		<tr><td>495</td><td>CMS55v2</td><td>Median Time from ED Arrival to ED Departure for Admitted ED Patients</td><td>RS3: ED and inpatient w/ psych</td><td>Emergency Department</td></tr>

		<tr><td>496</td><td>CMS32v3</td><td>Median Time from ED Arrival to ED Departure for Discharged ED Patients</td><td>Unstratified</td><td>Emergency Department</td></tr>

		<tr><td>497</td><td>CMS111v2</td><td>Median Admit Decision Time to ED Departure Time for Admitted Patients</td><td>RS3: ED and inpatient w/ psych</td><td>Emergency Department</td></tr>

		<tr><td>496</td><td>CMS32v3</td><td>Median Time from ED Arrival to ED Departure for Discharged ED Patients</td><td>RS3: With Acute care hospital transfer</td><td>Emergency Department</td></tr>

		<tr><td>496</td><td>CMS32v3</td><td>Median Time from ED Arrival to ED Departure for Discharged ED Patients</td><td>RS4: Without Mental Disorders and Acute care hospital transfer</td><td>Emergency Department</td></tr>

		<tr><td>497</td><td>CMS111v2</td><td>Median Admit Decision Time to ED Departure Time for Admitted Patients</td><td>Unstratified</td><td>Emergency Department</td></tr>

		<tr><td>495</td><td>CMS55v2</td><td>Median Time from ED Arrival to ED Departure for Admitted ED Patients</td><td>Unstratified</td><td>Emergency Department</td></tr>

		<tr><td>55</td><td>CMS131v2</td><td>Diabetes: Eye Exam</td><td>&nbsp;</td><td>Eye</td></tr>

		<tr><td>564</td><td>CMS132v2</td><td>Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures</td><td>&nbsp;</td><td>Eye</td></tr>

		<tr><td>565</td><td>CMS133v2</td><td>Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery</td><td>&nbsp;</td><td>Eye</td></tr>

		<tr><td>86</td><td>CMS143v2</td><td>Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation</td><td>&nbsp;</td><td>Eye</td></tr>

		<tr><td>&nbsp;</td><td>CMS61v3</td><td>Preventive Care and Screening: Cholesterol - Fasting Low Density Lipoprotein (LDL-C) Test Performed</td><td>Low Risk</td><td>General Practice Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS64v3</td><td>Preventive Care and Screening: Risk-Stratified Cholesterol – Fasting Low Density Lipoprotein (LDL-C)</td><td>LDL-C <160 mg/dL</td><td>General Practice Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS64v3</td><td>Preventive Care and Screening: Risk-Stratified Cholesterol – Fasting Low Density Lipoprotein (LDL-C)</td><td>LDL-C <130 mg/dL</td><td>General Practice Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS61v3</td><td>Preventive Care and Screening: Cholesterol - Fasting Low Density Lipoprotein (LDL-C) Test Performed</td><td>High Risk</td><td>General Practice Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS64v3</td><td>Preventive Care and Screening: Risk-Stratified Cholesterol – Fasting Low Density Lipoprotein (LDL-C)</td><td>LDL-C <100 mg/dL</td><td>General Practice Adult</td></tr>

		<tr><td>43</td><td>CMS127v2</td><td>Pneumonia Vaccination Status for Older Adults</td><td>&nbsp;</td><td>General Practice Adult</td></tr>

		<tr><td>32</td><td>CMS124v2</td><td>Cervical Cancer Screening</td><td>&nbsp;</td><td>General Practice Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS61v3</td><td>Preventive Care and Screening: Cholesterol - Fasting Low Density Lipoprotein (LDL-C) Test Performed</td><td>Moderate Risk</td><td>General Practice Adult</td></tr>

		<tr><td>34</td><td>CMS130v2</td><td>Colorectal Cancer Screening</td><td>&nbsp;</td><td>General Practice Adult</td></tr>

		<tr><td>101</td><td>CMS139v2</td><td>Falls: Screening for Future Fall Risk</td><td>&nbsp;</td><td>General Practice Adult</td></tr>

		<tr><td>31</td><td>CMS125v2</td><td>Breast Cancer Screening</td><td>&nbsp;</td><td>General Practice Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS65v3</td><td>Hypertension: Improvement in Blood Pressure</td><td>&nbsp;</td><td>General Practice Adult</td></tr>

		<tr><td>&nbsp;</td><td>CMS22v2</td><td>Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented</td><td>&nbsp;</td><td>General Practice Adult</td></tr>

		<tr><td>41</td><td>CMS147v2</td><td>Preventive Care and Screening: Influenza Immunization</td><td>&nbsp;</td><td>General Practice Pediatric</td></tr>

		<tr><td>75</td><td>CMS182v3</td><td>Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</td><td>Complete Lipid Profile</td><td>Heart</td></tr>

		<tr><td>70</td><td>CMS145v2</td><td>Coronary Artery Disease (CAD): Beta-Blocker Therapy—Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)</td><td>prior MI</td><td>Heart</td></tr>

		<tr><td>&nbsp;</td><td>CMS179v2</td><td>ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range</td><td>&nbsp;</td><td>Heart</td></tr>

		<tr><td>68</td><td>CMS164v2</td><td>Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic</td><td>&nbsp;</td><td>Heart</td></tr>

		<tr><td>70</td><td>CMS145v2</td><td>Coronary Artery Disease (CAD): Beta-Blocker Therapy—Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)</td><td>LVSD</td><td>Heart</td></tr>

		<tr><td>75</td><td>CMS182v3</td><td>Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</td><td>Most Recent LDL-C <100 mg/dL</td><td>Heart</td></tr>

		<tr><td>83</td><td>CMS144v2</td><td>Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)</td><td>&nbsp;</td><td>Heart</td></tr>

		<tr><td>81</td><td>CMS135v2</td><td>Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)</td><td>&nbsp;</td><td>Heart</td></tr>

		<tr><td>&nbsp;</td><td>CMS77v2</td><td>HIV/AIDS: RNA Control for Patients with HIV</td><td>&nbsp;</td><td>HIV</td></tr>

		<tr><td>405</td><td>CMS52v2</td><td>HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) prophylaxis</td><td><=3 Mon. of CD4 <500 cells/mm3 or CD4 <15%</td><td>HIV</td></tr>

		<tr><td>405</td><td>CMS52v2</td><td>HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) prophylaxis</td><td><=3 Mon. of CD4 <200 cells/mm3</td><td>HIV</td></tr>

		<tr><td>403</td><td>CMS62v2</td><td>HIV/AIDS: Medical Visit</td><td>&nbsp;</td><td>HIV</td></tr>

		<tr><td>405</td><td>CMS52v2</td><td>HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) prophylaxis</td><td>At Diagnosis of HIV</td><td>HIV</td></tr>

		<tr><td>480</td><td>CMS9v2</td><td>Exclusive Breast Milk Feeding</td><td>Refusals Excluded</td><td>Newborn</td></tr>

		<tr><td>716</td><td>CMS185v2</td><td>Healthy Term Newborn</td><td>&nbsp;</td><td>Newborn</td></tr>

		<tr><td>480</td><td>CMS9v2</td><td>Exclusive Breast Milk Feeding</td><td>All</td><td>Newborn</td></tr>

		<tr><td>1354</td><td>CMS31v2</td><td>Hearing Screening Prior To Hospital Discharge (EHDI-1a)</td><td>&nbsp;</td><td>Newborn</td></tr>

		<tr><td>&nbsp;</td><td>CMS66v2</td><td>Functional Status Assessment for Knee Replacement</td><td>&nbsp;</td><td>Orthopedics</td></tr>

		<tr><td>&nbsp;</td><td>CMS56v2</td><td>Functional Status Assessment for Hip Replacement</td><td>&nbsp;</td><td>Orthopedics</td></tr>

		<tr><td>608</td><td>CMS158v2</td><td>Pregnant women that had HBsAg testing</td><td>&nbsp;</td><td>Pregnancy</td></tr>

		<tr><td>469</td><td>CMS113v2</td><td>Elective Delivery</td><td>&nbsp;</td><td>Pregnancy</td></tr>

		<tr><td>441</td><td>CMS102v2</td><td>Assessed for Rehabilitation</td><td>&nbsp;</td><td>Stroke</td></tr>

		<tr><td>435</td><td>CMS104v2</td><td>Discharged on Antithrombotic Therapy</td><td>&nbsp;</td><td>Stroke</td></tr>

		<tr><td>436</td><td>CMS71v3</td><td>Anticoagulation Therapy for Atrial Fibrillation/Flutter</td><td>&nbsp;</td><td>Stroke</td></tr>

		<tr><td>438</td><td>CMS72v2</td><td>Antithrombotic Therapy By End of Hospital Day 2</td><td>&nbsp;</td><td>Stroke</td></tr>

		<tr><td>440</td><td>CMS107v2</td><td>Stroke Education</td><td>&nbsp;</td><td>Stroke</td></tr>

		<tr><td>437</td><td>CMS91v3</td><td>Thrombolytic Therapy</td><td>&nbsp;</td><td>Stroke</td></tr>

		<tr><td>439</td><td>CMS105v2</td><td>Discharged on Statin Medication</td><td>&nbsp;</td><td>Stroke</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>Vascular surgery</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>Knee arthroplasty</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>Colon surgery</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>CABG procedures</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>Hip arthroplasty</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>453</td><td>CMS178v3</td><td>Urinary catheter removed on Postoperative Day 1 (POD 1) or Postoperative Day 2 (POD 2) with day of surgery being day zero</td><td>&nbsp;</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>Abdominal hysterectomy</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>Vaginal hysterectomy</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>Other cardiac surgery</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>CABG procedures</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>Vaginal hysterectomy</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>Other cardiac surgery</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>Abdominal hysterectomy</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>Knee arthroplasty</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>528</td><td>CMS172v3</td><td>Prophylactic Antibiotic Selection for Surgical Patients</td><td>Hip arthroplasty</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>Colon surgery</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>527</td><td>CMS171v3</td><td>Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision</td><td>Vascular surgery</td><td>Surgical Care Improvement Project</td></tr>

		<tr><td>372</td><td>CMS190v2</td><td>Intensive Care Unit Venous Thromboembolism Prophylaxis</td><td>&nbsp;</td><td>Venous Thromboembolism</td></tr>

		<tr><td>374</td><td>CMS109v2</td><td>Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol or Nomogram</td><td>&nbsp;</td><td>Venous Thromboembolism</td></tr>

		<tr><td>376</td><td>CMS114v2</td><td>Incidence of Potentially-Preventable Venous Thromboembolism</td><td>&nbsp;</td><td>Venous Thromboembolism</td></tr>

		<tr><td>371</td><td>CMS108v2</td><td>Venous Thromboembolism Prophylaxis</td><td>&nbsp;</td><td>Venous Thromboembolism</td></tr>

		<tr><td>375</td><td>CMS110v2</td><td>Venous Thromboembolism Discharge Instructions</td><td>&nbsp;</td><td>Venous Thromboembolism</td></tr>

		<tr><td>373</td><td>CMS73v2</td><td>Venous Thromboembolism Patients with Anticoagulation Overlap Therapy</td><td>&nbsp;</td><td>Venous Thromboembolism</td></tr>

	</table>

</div>
